Pou1f1-KO Mouse
一般名
Pou1f1-KO
製品ID
S-KO-17690
背景情報
C57BL/6JCya
系統ID
KOCMP-18736-Pou1f1-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Pou1f1-KO Mouse(カタログ番号S-KO-17690)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Pou1f1-KO
系統ID
KOCMP-18736-Pou1f1-B6J-VA
遺伝子名
製品ID
S-KO-17690
遺伝子別名
dw, Hmp1, Pit1, GHF-1, Pit-1, dwarf, Pit1-rs1
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 16
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000176330
NCBIトランスクリプトID
NM_008849
ターゲット領域
Exon 4~5
有効領域の大きさ
~2.0 kb
遺伝子研究の概要
POU1F1, also known as POU Class 1 Homeobox1, is a pituitary-specific transcription factor. It plays a crucial role in the development and function of the anterior pituitary gland, regulating the expression of genes encoding growth hormone (GH), thyroid-stimulating hormone (TSH), and prolactin. It is involved in pathways related to growth, metabolism, and endocrine regulation, and its normal function is essential for overall physiological homeostasis. Genetic models, such as mouse models, are valuable for studying its functions [2,3,4,5,6].
Mice carrying the Pou1f1 c.143-83A>G substitution, which recapitulates a human intronic variant, showed postnatal growth failure, anterior pituitary hypoplasia, and deficiencies in circulating insulin-like growth factor 1 and thyroxine. RNA-seq and immunohistochemical analyses confirmed a reduction in somatotrophs. Reverse transcription polymerase chain reaction of pituitary Pou1f1 mRNA showed abnormal splicing, with changes in the ratios of alpha and beta isoforms and the emergence of an exon-skipped transcript [2]. In humans, POU1F1 mutations are prevalent in Indian combined pituitary hormone deficiency (CPHD) cohorts. Patients with these mutations often have severe GH, TSH, and prolactin deficiencies. Phenotype-genotype analysis revealed that patients with heterozygous mutations have milder phenotypes, including higher mean peak-GH levels and lower prevalence of anterior-pituitary hypoplasia compared to those with homozygous and compound heterozygous mutations [1]. Some patients with POU1F1 mutations also present with central precocious puberty or early puberty, although the relationship between the genotype and these pubertal phenotypes has not been firmly established. Animal studies suggest that the Pou1f1 gene may affect GnRH receptor function and the Gata2 gene, and control gonadotrope evolution [3].
In conclusion, POU1F1 is essential for the normal development and function of the anterior pituitary gland, regulating key hormones involved in growth and metabolism. Mouse models with specific Pou1f1 mutations have provided insights into the role of this gene in postnatal growth, pituitary development, and endocrine function. In humans, POU1F1 mutations are associated with CPHD and some pubertal abnormalities, highlighting the gene's significance in understanding these disease conditions [1,2,3].
References:
1. Jadhav, Swati, Diwaker, Chakra, Lila, Anurag R, Shah, Nalini S, Bandgar, Tushar R. 2021. POU1F1 mutations in combined pituitary hormone deficiency: differing spectrum of mutations in a Western-Indian cohort and systematic analysis of world literature. In Pituitary, 24, 657-669. doi:10.1007/s11102-021-01140-9. https://pubmed.ncbi.nlm.nih.gov/33742319/
2. Akiba, Kazuhisa, Hasegawa, Yukihiro, Katoh-Fukui, Yuko, Fukami, Maki, Narumi, Satoshi. . POU1F1/Pou1f1 c.143-83A > G Variant Disrupts the Branch Site in Pre-mRNA and Leads to Dwarfism. In Endocrinology, 164, . doi:10.1210/endocr/bqac198. https://pubmed.ncbi.nlm.nih.gov/36427334/
3. Baş, Firdevs, Abalı, Zehra Yavaş, Toksoy, Güven, Uyguner, Zehra Oya, Darendeliler, Feyza. 2018. Precocious or early puberty in patients with combined pituitary hormone deficiency due to POU1F1 gene mutation: case report and review of possible mechanisms. In Hormones (Athens, Greece), 17, 581-588. doi:10.1007/s42000-018-0079-4. https://pubmed.ncbi.nlm.nih.gov/30460459/
4. Gangat, Mariam, Radovick, Sally. 2017. Pituitary Hypoplasia. In Endocrinology and metabolism clinics of North America, 46, 247-257. doi:10.1016/j.ecl.2017.01.003. https://pubmed.ncbi.nlm.nih.gov/28476222/
5. Bosch I Ara, Laura, Katugampola, Harshini, Dattani, Mehul T. 2021. Congenital Hypopituitarism During the Neonatal Period: Epidemiology, Pathogenesis, Therapeutic Options, and Outcome. In Frontiers in pediatrics, 8, 600962. doi:10.3389/fped.2020.600962. https://pubmed.ncbi.nlm.nih.gov/33634051/
6. Bando, Hironori, Brinkmeier, Michelle L, Castinetti, Frederic, Brue, Thierry, Camper, Sally A. . Heterozygous variants in SIX3 and POU1F1 cause pituitary hormone deficiency in mouse and man. In Human molecular genetics, 32, 367-385. doi:10.1093/hmg/ddac192. https://pubmed.ncbi.nlm.nih.gov/35951005/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
